174 related articles for article (PubMed ID: 19567255)
1. A biodegradable filament for controlled drug delivery.
Mack BC; Wright KW; Davis ME
J Control Release; 2009 Nov; 139(3):205-11. PubMed ID: 19567255
[TBL] [Abstract][Full Text] [Related]
2. In vitro / in vivo evaluation of NCDS-micro-fabricated biodegradable implant.
Park CW; Rhee YS; Park SH; Danh SD; Ahn SH; Chi SC; Park ES
Arch Pharm Res; 2010 Mar; 33(3):427-32. PubMed ID: 20361308
[TBL] [Abstract][Full Text] [Related]
3. Biodegradable polyesterurethanes with shape-memory properties for dexamethasone and aspirin controlled release.
Feng Y; Zhang S; Wang H; Zhao H; Lu J; Guo J; Behl M; Lendlein A
J Control Release; 2011 Nov; 152 Suppl 1():e21-3. PubMed ID: 22195859
[No Abstract] [Full Text] [Related]
4. A biodegradable drug delivery system for the treatment of postoperative inflammation.
Eperon S; Bossy-Nobs L; Petropoulos IK; Gurny R; Guex-Crosier Y
Int J Pharm; 2008 Mar; 352(1-2):240-7. PubMed ID: 18093765
[TBL] [Abstract][Full Text] [Related]
5. Water-free microencapsulation of proteins within PLGA microparticles by spray drying using PEG-assisted protein solubilization technique in organic solvent.
Mok H; Park TG
Eur J Pharm Biopharm; 2008 Sep; 70(1):137-44. PubMed ID: 18515053
[TBL] [Abstract][Full Text] [Related]
6. Development of an in situ forming PLGA drug delivery system I. Characterization of a non-aqueous protein precipitation.
Körber M; Bodmeier R
Eur J Pharm Sci; 2008 Nov; 35(4):283-92. PubMed ID: 18721875
[TBL] [Abstract][Full Text] [Related]
7. In vitro study on tamsulosin release kinetics from biodegradable PLGA in situ implants.
Elias-Al-Mamun M; Khan HA; Dewan I; Jalil RU
Pak J Pharm Sci; 2009 Oct; 22(4):360-7. PubMed ID: 19783512
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of in vivo-in vitro release of dexamethasone from PLGA microspheres.
Zolnik BS; Burgess DJ
J Control Release; 2008 Apr; 127(2):137-45. PubMed ID: 18282629
[TBL] [Abstract][Full Text] [Related]
9. Fabrication of covered porous PLGA microspheres using hydrogen peroxide for controlled drug delivery and regenerative medicine.
Bae SE; Son JS; Park K; Han DK
J Control Release; 2009 Jan; 133(1):37-43. PubMed ID: 18838089
[TBL] [Abstract][Full Text] [Related]
10. Drug release from biodegradable polyesterurethanes with shape-memory effect.
Feng Y; Zhang S; Wang H; Zhao H; Lu J; Guo J; Behl M; Lendlein A
J Control Release; 2011 Nov; 152 Suppl 1():e20-1. PubMed ID: 22195852
[No Abstract] [Full Text] [Related]
11. Structure formation and characterization of injectable drug loaded biodegradable devices: in situ implants versus in situ microparticles.
Kranz H; Bodmeier R
Eur J Pharm Sci; 2008 Jul; 34(2-3):164-72. PubMed ID: 18501569
[TBL] [Abstract][Full Text] [Related]
12. Thermal behavior and stability of biodegradable spray-dried microparticles containing triamcinolone.
da Silva AA; de Matos JR; Formariz TP; Rossanezi G; Scarpa MV; do Egito ES; de Oliveira AG
Int J Pharm; 2009 Feb; 368(1-2):45-55. PubMed ID: 18992313
[TBL] [Abstract][Full Text] [Related]
13. Solvent-free biodegradable scleral plugs providing sustained release of vancomycin, amikacin, and dexamethasone--an in vivo study.
Peng YJ; Kau YC; Wen CW; Liu KS; Liu SJ
J Biomed Mater Res A; 2010 Aug; 94(2):426-32. PubMed ID: 20186737
[TBL] [Abstract][Full Text] [Related]
14. In situ micro-sized gel-forming injectable implant using biodegradable amphiphilic graft copolymer.
Cho KY; Lee S; Park JK
Macromol Biosci; 2007 Jun; 7(6):784-8. PubMed ID: 17541923
[TBL] [Abstract][Full Text] [Related]
15. Insulin-loaded PLGA/cyclodextrin large porous particles with improved aerosolization properties: in vivo deposition and hypoglycaemic activity after delivery to rat lungs.
Ungaro F; d'Emmanuele di Villa Bianca R; Giovino C; Miro A; Sorrentino R; Quaglia F; La Rotonda MI
J Control Release; 2009 Apr; 135(1):25-34. PubMed ID: 19154761
[TBL] [Abstract][Full Text] [Related]
16. Drug release from injectable depots: two different in vitro mechanisms.
Wang L; Venkatraman S; Kleiner L
J Control Release; 2004 Sep; 99(2):207-16. PubMed ID: 15380631
[TBL] [Abstract][Full Text] [Related]
17. The effect of formulation variables on the characteristics of insulin-loaded poly(lactic-co-glycolic acid) microspheres prepared by a single phase oil in oil solvent evaporation method.
Hamishehkar H; Emami J; Najafabadi AR; Gilani K; Minaiyan M; Mahdavi H; Nokhodchi A
Colloids Surf B Biointerfaces; 2009 Nov; 74(1):340-9. PubMed ID: 19717287
[TBL] [Abstract][Full Text] [Related]
18. Extrusion printed polymer structures: a facile and versatile approach to tailored drug delivery platforms.
Rattanakit P; Moulton SE; Santiago KS; Liawruangrath S; Wallace GG
Int J Pharm; 2012 Jan; 422(1-2):254-63. PubMed ID: 22101281
[TBL] [Abstract][Full Text] [Related]
19. Fabrication of multi-layered biodegradable drug delivery device based on micro-structuring of PLGA polymers.
Ryu WH; Vyakarnam M; Greco RS; Prinz FB; Fasching RJ
Biomed Microdevices; 2007 Dec; 9(6):845-53. PubMed ID: 17577671
[TBL] [Abstract][Full Text] [Related]
20. Controlled delivery of aspirin: effect of aspirin on polymer degradation and in vitro release from PLGA based phase sensitive systems.
Tang Y; Singh J
Int J Pharm; 2008 Jun; 357(1-2):119-25. PubMed ID: 18329202
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
